Press Release

Intellectual Ventures Acquires Transmeta Patent Portfolio

January 28, 2009 BELLEVUE, Wash.

Intellectual Venture Funding LLC, an affiliate of Intellectual Ventures, completed the acquisition of the patent portfolio formerly developed and owned by Transmeta Corporation. This transaction follows the acquisition of formerly publicly traded Transmeta by privately held Novafora, Inc.

Today, Intellectual Venture Funding LLC, an affiliate of Intellectual Ventures, completed the acquisition of the patent portfolio formerly developed and owned by Transmeta Corporation. This transaction follows the acquisition of formerly publicly traded Transmeta by privately held Novafora, Inc.

With this transaction, Intellectual Venture Funding LLC acquired more than 140 U.S. patents and a substantial number of pending patent applications. The transaction also includes patents and patent applications in countries beyond the United States.

With the completion of these two transactions, the technology developed by Transmeta for more than a decade will be used further through two distinct routes:

  1. Novafora’s improving its own proprietary designs by using some of the technologies invented by Transmeta, and
  2. Intellectual Ventures providing other companies with access to Transmeta’s former patent rights under non-exclusive licensing terms.

“This transaction demonstrates how Intellectual Ventures’ unique business model can enhance the creation, dissemination, and use of technological inventions. When technologies from multiple sources are combined, or when patent rights from many inventors are combined, the original inventions can now find a home in new applications and in new companies,” said Vincent Pluvinage, PhD, who leads strategic intellectual property acquisitions and private equity partnerships at Intellectual Ventures.

This portfolio contains relatively young patents; many were issued in the last few years. Transmeta licensed these patents to several of the largest microprocessor companies to generate revenue of approximately $300 million. The company was a pioneer in low-power microprocessor technology, “code morphing” techniques, and very long instruction word design architecture.

“The acquisition of the Transmeta semiconductor patents augments one of the most comprehensive patent portfolios in the semiconductor field, which now includes more than 2,000 patents. This benefits our current and potential licensees by providing more access to innovation and greater opportunity for commercial success,” said Paul Reidy, vice president of semiconductor licensing at Intellectual Ventures. “These additions cover inventions in high-performance, low-power, and embedded processors. Some of the recently issued patents detail some of the most interesting breakthroughs in microprocessor architecture we’ve seen in the last decade or so.”

Tags

Sorry, no tags exist

More Buzz From IV

Introducing “Failing for Success”

Over the coming weeks, we’ll be rolling out some of these stories alongside personal anecdotes from IV inventors and innovators in our brand new series: “Failing for Success.”

Read More
Innovating for a Cure — Dr. Mary-Claire King: Pioneering Advocate and Geneticist

In honor of Breast Cancer Awareness Month, Intellectual Ventures is celebrating two visionaries in the Seattle area whose ideas about what the future holds in the fight against breast cancer is changing lives.

Read More
Cory Van Arsdale on licensing, collaboration and the future of patenting

Part of our business involves providing customers and partners worldwide with patents and invention-related services. As a result, Senior Vice President of Global Licensing Cory Van Arsdale has great perspective on the state of the global intellectual property ecosystem.

Read More